Statement: Agatha had her 50th birthday last week, she has a histologically confirmed adenocarcinoma of the breast, with no evidence of metastatic disease. She is eligible for the primary trial but not the secondary trial.
Primary_evidence: Inclusion Criteria:   female patients 18-70 years of age;   adenocarcinoma of the breast;   previous invasive breast cancer if diagnosed >5 years before entering study;   no evidence of metastatic disease. Exclusion Criteria:   history of severe hypersensitivity reaction to Taxotere;   previous treatment with anthracycline, anthracenedione (mitoxantrone), or taxane;   treatment with fluoropyrimidine (5-fluorouracil) within the last 5 years.
Secondary_evidence: Inclusion Criteria:   Age 52-75 years old;   Identification as Latina/Hispanic/Chicana female;   Residence in Pilsen, Little Village, East Side or South Chicago;   No history of health volunteerism;   No history of breast cancer; and   Lack of a mammogram within the last two years Exclusion Criteria:   Not meeting all inclusion criteria;   Women will be excluded if they participated in formative focus groups